FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2563249905> ?p ?o ?g. }

• W2563249905 endingPage "1556" @default.
• W2563249905 startingPage "1543" @default.
• W2563249905 abstract "Diseases of the liver related to metabolic syndrome have emerged as the most common and undertreated hepatic ailments. The cause of nonalcoholic fatty liver disease is the aberrant accumulation of lipid in hepatocytes, though the mechanisms whereby this leads to hepatocyte dysfunction, death, and hepatic fibrosis are still unclear. Insulin‐sensitizing thiazolidinediones have shown efficacy in treating nonalcoholic steatohepatitis (NASH), but their widespread use is constrained by dose‐limiting side effects thought to be due to activation of the peroxisome proliferator–activated receptor γ. We sought to determine whether a next‐generation thiazolidinedione with markedly diminished ability to activate peroxisome proliferator–activated receptor γ (MSDC‐0602) would retain its efficacy for treating NASH in a rodent model. We also determined whether some or all of these beneficial effects would be mediated through an inhibitory interaction with the mitochondrial pyruvate carrier 2 (MPC2), which was recently identified as a mitochondrial binding site for thiazolidinediones, including MSDC‐0602. We found that MSDC‐0602 prevented and reversed liver fibrosis and suppressed expression of markers of stellate cell activation in livers of mice fed a diet rich in trans‐fatty acids, fructose, and cholesterol. Moreover, mice with liver‐specific deletion of MPC2 were protected from development of NASH on this diet. Finally, MSDC‐0602 directly reduced hepatic stellate cell activation in vitro , and MSDC‐0602 treatment or hepatocyte MPC2 deletion also limited stellate cell activation indirectly by affecting secretion of exosomes from hepatocytes. Conclusion : Collectively, these data demonstrate the effectiveness of MSDC‐0602 for attenuating NASH in a rodent model and suggest that targeting hepatic MPC2 may be an effective strategy for pharmacologic development. (H epatology 2017;65:1543‐1556)." @default.
• W2563249905 created "2017-01-06" @default.
• W2563249905 creator A5007616119 @default.
• W2563249905 creator A5009582773 @default.
• W2563249905 creator A5021060288 @default.
• W2563249905 creator A5045734619 @default.
• W2563249905 creator A5063292939 @default.
• W2563249905 creator A5066051920 @default.
• W2563249905 creator A5068685773 @default.
• W2563249905 creator A5072014736 @default.
• W2563249905 creator A5075010024 @default.
• W2563249905 creator A5090313762 @default.
• W2563249905 date "2017-03-30" @default.
• W2563249905 modified "2023-10-17" @default.
• W2563249905 title "Targeting the mitochondrial pyruvate carrier attenuates fibrosis in a mouse model of nonalcoholic steatohepatitis" @default.
• W2563249905 cites W1868475579 @default.
• W2563249905 cites W1908780918 @default.
• W2563249905 cites W1928389510 @default.
• W2563249905 cites W1932854961 @default.
• W2563249905 cites W1963534279 @default.
• W2563249905 cites W1963683487 @default.
• W2563249905 cites W1964572117 @default.
• W2563249905 cites W1965712234 @default.
• W2563249905 cites W1974142271 @default.
• W2563249905 cites W1981961082 @default.
• W2563249905 cites W1997671539 @default.
• W2563249905 cites W2003110890 @default.
• W2563249905 cites W2014718725 @default.
• W2563249905 cites W2019280401 @default.
• W2563249905 cites W2020195767 @default.
• W2563249905 cites W2022184946 @default.
• W2563249905 cites W2031402631 @default.
• W2563249905 cites W2047591801 @default.
• W2563249905 cites W2048613643 @default.
• W2563249905 cites W2052478346 @default.
• W2563249905 cites W2054277796 @default.
• W2563249905 cites W2059700860 @default.
• W2563249905 cites W2062410076 @default.
• W2563249905 cites W2062812115 @default.
• W2563249905 cites W2063437798 @default.
• W2563249905 cites W2067740038 @default.
• W2563249905 cites W2076233566 @default.
• W2563249905 cites W2088631644 @default.
• W2563249905 cites W2094229041 @default.
• W2563249905 cites W2108698393 @default.
• W2563249905 cites W2128009079 @default.
• W2563249905 cites W2129275826 @default.
• W2563249905 cites W2129679875 @default.
• W2563249905 cites W2151293178 @default.
• W2563249905 cites W2164556013 @default.
• W2563249905 cites W2165311378 @default.
• W2563249905 cites W2204688218 @default.
• W2563249905 cites W2276317604 @default.
• W2563249905 cites W2291072797 @default.
• W2563249905 cites W2326389904 @default.
• W2563249905 cites W2363676876 @default.
• W2563249905 cites W2401657071 @default.
• W2563249905 cites W2417631794 @default.
• W2563249905 cites W2467705229 @default.
• W2563249905 cites W2470709274 @default.
• W2563249905 cites W2509033031 @default.
• W2563249905 cites W2553298154 @default.
• W2563249905 cites W4245059944 @default.
• W2563249905 doi "https://doi.org/10.1002/hep.29025" @default.
• W2563249905 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5397348" @default.
• W2563249905 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28027586" @default.
• W2563249905 hasPublicationYear "2017" @default.
• W2563249905 type Work @default.
• W2563249905 sameAs 2563249905 @default.
• W2563249905 citedByCount "103" @default.
• W2563249905 countsByYear W25632499052017 @default.
• W2563249905 countsByYear W25632499052018 @default.
• W2563249905 countsByYear W25632499052019 @default.
• W2563249905 countsByYear W25632499052020 @default.
• W2563249905 countsByYear W25632499052021 @default.
• W2563249905 countsByYear W25632499052022 @default.
• W2563249905 countsByYear W25632499052023 @default.
• W2563249905 crossrefType "journal-article" @default.
• W2563249905 hasAuthorship W2563249905A5007616119 @default.
• W2563249905 hasAuthorship W2563249905A5009582773 @default.
• W2563249905 hasAuthorship W2563249905A5021060288 @default.
• W2563249905 hasAuthorship W2563249905A5045734619 @default.
• W2563249905 hasAuthorship W2563249905A5063292939 @default.
• W2563249905 hasAuthorship W2563249905A5066051920 @default.
• W2563249905 hasAuthorship W2563249905A5068685773 @default.
• W2563249905 hasAuthorship W2563249905A5072014736 @default.
• W2563249905 hasAuthorship W2563249905A5075010024 @default.
• W2563249905 hasAuthorship W2563249905A5090313762 @default.
• W2563249905 hasBestOaLocation W25632499051 @default.
• W2563249905 hasConcept C126322002 @default.
• W2563249905 hasConcept C134018914 @default.
• W2563249905 hasConcept C176891718 @default.
• W2563249905 hasConcept C202751555 @default.
• W2563249905 hasConcept C2776200302 @default.
• W2563249905 hasConcept C2776923340 @default.
• W2563249905 hasConcept C2776954865 @default.
• W2563249905 hasConcept C2777180221 @default.
• W2563249905 hasConcept C2778772119 @default.

• next